Squamous cell carcinoma antigen suppresses radiation-induced cell death by Murakami, A et al.
Squamous cell carcinoma antigen (SCCA) was first found in the
uterine cervical squamous cell carcinoma (SCC) by Kato and
Torigoe (1977). The serum level of SCCA is increased in parallel
to the growth of the tumour size or the recurrence of the disease.
Therefore, measurement of the serum level of SCCA has been
used clinically for the diagnosis and the management of SCC of
the uterine cervix as well as other various organs (Kato et al, 1982,
1983; Maruo et al, 1985; Mino et al, 1988; Brioschi et al, 1991). 
In a previous report, this tumour marker has been reported to be
separated into two fractions (a neutral form and an acidic form) by the
column isoelectric focusing (Kato et al, 1984). The netural form was
present in both SCC and normal squamous cells with pI ³ 6.25,
whereas the acidic form, with pI< 6.25, was increased mainly in SCC
and was released easily into the outside of the cells (Kato et al, 1984).
The cDNA of human SCCA1 gene was first isolated and reported by
Suminami et al (1991). Recently, a second SCCA gene, SCCA2, was
identified and was arrayed with SCCA1 gene on the chromosome
18q21.3 (Kuwano et al, 1995; Schneider et al, 1995). Sequences of
SCCA1 and SCCA2 cDNAs are highly homologous (95%) and the
predicted amino acid sequence analyses indicate that SCCA1 and
SCCA2 sequences share 92% identical residues overall with ident-
ical secondary structures (Schneider et al, 1995). Two-dimensional
analyses of recombinant SCCA1 and SCCA2 indicated that SCCA1
encoded spots with pI6.4, 6.3, 6.0 and 5.9 (two neutral forms and two
acidic forms in the previous criteria), whereas SCCA2 encoded spots
with pI 5.5 and 5.3 (two acidic forms) (Murakami et al, 2000).
Quantitative analyses of SCCA1 and SCCA2 mRNAs showed that
SCCA2 mRNA expressed in SCC tissues was higher than that in
normal tissues, while SCCA1 mRNA did not show significant differ-
ences between them (Murakami et al, 2000). 
Both SCCA belong to the ovalbumin-serine proteinase inhibitor
(ov-serpin) family (Suminami et al, 1991; Remold-O’Donnell,
1993; Schneider et al, 1995). Ov-serpins have unique characteris-
tics which distinguish them from other members of the serpin
superfamily. While most serpins are secreted and work extracellu-
lary, ov-serpins are intracellular proteinase inhibitors, which are
secreted only occasionally, without a signal sequence, by unknown
mechanisms (Belin et al, 1989). Recombinant SCCA1 actually has
the inhibitory activities of serine proteinase such as chymotrypsin
and cysteine proteinases such as cathepsin L, K, S and papain,
while SCCA2 is able to inhibit serine proteinases such as
cathepsin G and mast cell chymase in vitro (Nawata et al, 1995,
1997; Sehick et al, 1997, 1998). Therefore, it was speculated 
that SCCA1 and SCCA2 might have some different biological 
functions. 
Apoptosis, the process of programmed cell death, can be initi-
ated at the cell surface by activation of cell death signals that are
transmitted to both the cytoplasm and the nucleus to induce
proteolysis and DNA fragmentation (Kerr et al, 1972; Wyllie et al,
1980). Among the apoptotic stimuli, TNF-a, Fas and extracellular
stresses such as g irradiation, UV irradiation, anticancer drugs and
osmotic shock activate stress-activated mitogen-activated protein
kinase (MAPK) such as p38 and stress-activated protein kinase
(SAPK) (Sluss et al, 1994; Xia et al, 1995; Chen et al, 1996a,
1996b, 1999; Brenner et al, 1997). 
The p38 MAPK and SAPK are themselves phosphorylated and
activated by the upstream kinases. p38 MAPK is activated by
phosphorylated MAPK kinase (MKK) 3, MKK4 and MKK6 (Xia
et al, 1995; Chen et al, 1999). These upstream kinases are also
phosphorylated and activated by further upstream kinases (Hibi 
et al, 1993; Chen et al, 1999). 
Because cancer therapy uses stresses such as radiation therapy
and chemotherapy, which induce apoptosis, failure to undergo
apoptosis may contribute to the resistance of cancer cells to these
therapeutic modalities. For example, many cancer cells express the
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Bcl-2 does not always indicate poor prognosis (Furuya et al,
1996; Krajewska et al, 1996). It was reported that intracellular
proteinases mediate apoptosis, and on the other hand, proteinase
inhibitors are involved in the regulation of apoptosis (Tewari and
Dixit, 1995; Tewari et al, 1995a, 1995b; Alnemri et al, 1996).
Among the serpin family, Crm A and PAI-2 have been reported to
suppress apoptosis in the infection and inflammation processes.
Recently we reported that SCCA1 suppressed apoptosis induced
by anti-cancer agents TNF-a or natural killer cells in vitro, and
SCCA1 transduced cells grew faster in vivo (Suminami et al,
2000). These data suggest that the existence of SCCA1 makes
cancer cells resistant by suppressing apoptosis (Suminami et al,
2000). However, the effect of SCCA2 to apoptosis has been
unclear. 
In this report, we show that not only SCCA1, but also SCCA2,
attenuate radiation-induced apoptosis in vitro. Caspase 3 activity
and activation of caspase 9 were suppressed in SCCA-transfected
cells than those of the control cells. Furthermore, we indicated that
SCCA suppresses p38 MAPK pathway in the radiation-induced
apoptosis. 
MATERIALS AND METHODS 
Cell lines 
A human renal epithelial cell line 293T, which was transformed
with adenovirus E1a and SV40 large T antigen, was maintained 
in Eagle’s minimal essential medium (EMEM) (Gibco BRL,
Gaithersburg) supplemented with 10% fetal calf serum (FCS), 2
mM glutamine, 100 mg ml–1 streptomycin, and 100 U ml–1 peni-
cillin (Numa et al, 1995). Human uterine cervical cancer cell line
SKG IIIa, which expresses SCCA, was kindly provided by Dr S
Nozawa (Keio University, Tokyo) (Nozawa et al, 1990). This cell
line was grown in Ham’s F12 (Dainippon Pharmaceutical, Tokyo)
supplemented with 5% FCS, 100 U ml–1 penicillin, 100 mg ml–1
streptomycin and 2 mM glutamine at 37˚C in a humidified 5%
CO2 incubator. 
Construction of the expression vectors 
The coding regions of SCCA1 and SCCA2 cDNAs were amplified
by reverse transcription (RT)-PCR. The first-strand cDNA was
generated by incubation of 1 mg of total RNA extracted from SKG
IIIa in 20 ml of RT reaction mixture with final concentration of
10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2 mM MgCl2, 1 U ml– 1
RNase inhibitor (Perkin Elmer, Norwalk), 2.5 U ml–1 MuLV
reverse transcriptase (Perkin Elmer), 1 mM dNTPs and 2.5 mM of
Oligo d (T)16 (Perkin Elmer). The incubation was performed at
42˚C for 15 min followed by heat-inactivation of the enzyme at
99˚C for 5 min. 
Following RT reaction, PCR was performed in 50 ml of mixture
with final concentration of 10 mM Tris-HCl (pH 8.3), 50 mM
KCl, 5 mM MgCl2, 0.2 mM dNTPs, 0.025 U ml–1 of Ampli Taq
DNA polymerase (Perkin Elmer) and the following primers: Sense
primer, 5¢-TCACCATGAATTCACTCAG-3¢; antisense primer, 
5¢-TCTATGGGGATGAGAATCT-3¢. The reaction was performed
at 94˚C for 2 min followed by 30 cycles of 94˚C for 1 min, 58˚C
for 30 s and 72˚C for 2 min, and final extension at 72˚C for
10 min. The RT-PCR products were ligated with pCR II vector
(Invitrogen, Carlsbad) and the nucleotide sequences of the ligated
products (pCR II-SCCA1 and pCR II-SCCA2) were confirmed by
the dideoxy nucleotide chain termination method using automated
DNA sequencing apparatus of LI-COR 4000LS (LI-COR Inc,
Lincoln). 
The XhoI fragments of pCR II-SCCA1 and pCR II-SCCA2
containing full length of coding region of SCCA1 and  SCCA2
cDNAs were ligated with XhoI site of the eukaryote expression
vector pCEP4 (Invitrogen) and the direction was confirmed. These
constructs (pCEP4-SCCA1 and pCEP4-SCCA2) and the control
construct without SCCA cDNA were used for the transfection. 
Gene transfection 
Cultured 293T cells were plated at density of approximately
3  ´ 105 cells per 35 mm dish (Becton Dickinson, Foster City). On
the day of transfection, the cultured cells were washed with Opti-
MEM medium (Gibco BRL) and transfected with 2.5 mg of
pCEP4-SCCA1, pCEP4-SCCA2, or the vector alone by the poly-
amine transfection method (TransIT-LT1, Pan Vera, Madison),
according to the manufacturer’s instructions. Cells were cultured
in EMEM containing 10% FCS and 200 mgm l –1 hygromycin B
(Sigma, St. Louis) for 6 weeks of incubation for selecting the
independent clones (SCCA1: 293T-SCCA1-1 and 293T-SCCA1-2;
SCCA2: 293T-SCCA2-1 and 293T-SCCA2-2). 
Expression of the SCCA cDNA in the transfected cells 
The expression of SCCA1 and SCCA2 in parent cells and
hygromycin-resistant cells were confirmed by semi-quantitative
RT-PCR. It was performed with RNA-PCR core kit (Perkin
Elmer) according to the manufacture’s protocol with amplifying
primer pair for SCCA1 and  SCCA2 cDNA (sense primer,
5¢-GTTGGATCCAACAAGCTCTTCGGAGA-3¢; antisense primer,
5¢-CCGTCGACTCTACGGGGATGAGAATCT-3¢) or L-19 amplify-
ing primer pair (sense primer, 5¢-CTGAAGGTCAAAGG-
GAATGTG-3¢; antisense primer, 5¢-GGACAGAGTCTTGATG
ATCTC-3¢). RT reaction was performed with 1 mg of total RNA
and RT condition was described above. PCR was done with
28 cycles (confirmed in the preliminary experiments to be in the
exponential phase) of 94˚C, 58˚C, and 72˚C each for 1 min, by
adding 0.1 ml of [a-32P] dCTP. Radioactivity of the PCR bands
were counted with Bioimaging analyser BAS 2000 (Fuji Film,
Tokyo) and the ratio of the counts obtained with the SCCA1 or
SCCA2, and L19 was calculated. 
The transfected cells were resuspended in ice-cold PBS, soni-
cated mildly, and next centrifuged at 15 000 rpm for 10 min at
4˚C. The expression level of SCCA protein in cell lysate of the
transfected cells was confirmed by IMx system (DaiNabot, Tokyo)
(Takeshima et al, 1990). 
Cell growth assay 
The transfected cells were seeded on a 96-well plate (2 ´ 103 cells
well–1). After 1, 3 and 5 days, 150 ml of 3-[4,5-dimethylthiazol-
2-yl]-2, 5-diphenyltetrazolium bromide (MTT) (0.5 mg ml–1 in
culture medium) was added per well, and the incubation was
continued for a further 4 h. The medium was then aspirated, and
the cells were dissolved in 150 ml of dimethyl sulfoxide (DMSO)
and the absorbance at 540 nm was measured with a microplate
reader (Toso, Tokuyama). 
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The transfected cells were seeded on 96-well plate (5 ´ 103 cells
well–1). After 24 h of incubation, these cells were exposed to the
radiation at 0, 5 or 20 Gy. Incubation was continued for another
36 h, and cells were collected and used for the detection of
mRNAs and proteins. Viability of cells was determined at 12, 24
and 36 h of incubation by MTT assay as described above. 
Expression levels of bax and bcl-2 mRNAs 
Total cellular RNAs were extracted using RNeasy kit (Quiagen,
Hilden) according to the manufacturer’s protocol. Semi-quantitative
RT-PCR was performed using RNA-PCR core kit (Perkin Elmer)
following the manufacturer’s protocol with the bcl-2 or bax primer
pairs: bcl-2, 5¢-GACTTCGCCGAGATGTCCAG-3¢ (sense primer)
and 5¢-TCACTTGTGGCTCAGATAGG-3¢ (antisense primer);
bax, 5¢-GGTTTCATCCAGGATCGAGACGG-3¢ (sense primer) and
5¢-ACAAAGATGGTCACGGTCTGCC-3¢ (antisense primer). 
RT reaction was performed with 1.0 mg of total RNA and RT
condition was described above. PCR was done with 28 cycles
(confirmed in the preliminary experiments to be in the exponential
phase) of 94˚C for 1 min, 60˚C for 1 min and 72˚C for 1.5 min for
amplifying bcl-2 mRNA, and 94˚C for 1 min, 50˚C for 1 min and
72˚C for 2 min for amplifying bax mRNA, by adding 0.1 ml of [a-
32P] dCTP. Radioactivity of each PCR band was counted with
Bioimaging analyser BAS 2000 and the ratio of the obtained
counts with the bcl-2 or bax, and L19 were calculated. 
Detection of caspase 2, 8 and 9 expression and
caspase 3 activity 
Caspase 2, caspase 8, and caspase 9 were detected by SDS-
polyacrylamide gel electrophoresis (PAGE) and the immuno-
chemical technique. Fifty-five mg of total protein in each lane was
electrophoresed on 12.5% polyacrylamide gel. After SDS-PAGE
was completed, proteins were transferred to the polyvinylidene
difluoride (PVDF) membrane (ATTO, Tokyo) with semi-dry type
blotting. The transferred membranes were stained by immuno-
chemical technique which consisted of the following procedure:
after blocking the membrane with blocking solution (5% skimmed
milk with 0.1% Tween 20 dissolved in Tris buffered saline, pH
7.5), the blotted membranes were incubated with polyclonal anti-
body against caspase 2 [caspase-2 (C-20)-G], caspase 8 [Mch 5
p20 (T-16)] (SantaCruz Biotechnology, Delaware), or caspase 9
(New England Biolabs, Beverly), which were diluted in blocking
solution (1:2000). Then these membranes were incubated with
peroxidase conjugated rabbit anti-goat IgG antibody (caspase 2
and caspase 8) or swine anti-rabbit IgG antibody (caspase 9)
diluted in the blocking solution. Finally, ECL-Western blotting
detection system (Amersham, Aylesburg) was applied according to
the manufacture’s protocol and then the membranes were exposed
to the hyperfilm-ECL (Amersham). 
Caspase 3 activity was measured by using ApoAlert CPP32
protease assay kit (Clontech, Palo Alto) according to the manufac-
ture’s protocol. The treated cells were harvested, counted, lysed
with the cell lysis buffer and centrifuged. After incubation with the
substrate for 1 h at 37˚C, the caspase 3 activity was obtained by
measuring OD400. 
Expression levels of p38 MAPK and SAPK/JNK 
Approximately 1 ´ 106 of the irradiated cells were collected in one
tube and Laemmli’s loading buffer was added to the collected cells
and the cells were mildly sonicated. After sonication, products
were boiled for 5 min and were centrifuged at 15 000 rpm for 15
min at 4˚C. The treated samples of the same volume were elec-
trophoresed on 12.5% polyacrylamide gel. After SDS-PAGE was
completed, proteins were transferred to the PVDF membrane and
blocking procedures were performed as described above. 
The membranes were treated as follows: after blocking the
membrane in the blocking solution, immunoblotting was done to
detect p38 MAPK, phosphorylated p38 MAPK, phosphorylated
MKK3/MKK6 and phosphorylated SAPK/JNK using p38 
MAPK, phospho-p38 MAPK (Thr180/Tyr182), phospho-MKK3/
MKK6 (Ser189/207) and phospho-SAPK/JNK (Thr183/Tyr185)
antibodies, respectively (New England Biolabs). Then the
membranes were incubated with peroxidase conjugated swine
anti-rabbit IgG antibody (p38 MAPK, phospho-p38 MAPK and
phospho-MKK3/MKK6) or rabbit anti-mouse IgG antibody
(phospho-SAPK/JNK), and developed as described above. 
Statistical analysis 
Statistical analysis was done by Duncan’s new multiple range test.
A probability value of <0.05 was considered to be significant. 
RESULTS 
Establishment of the expressing clones of SCCA1 and
SCCA2 
To analyse the functions of the SCCA in tumour cells, we estab-
lished the stable clones expressing SCCA. A human kidney cell
line 293T, which did not express SCCA, was transfected with
eukaryotic expression vector containing SCCA1, SCCA2 cDNA or
vector alone as a control cell. To examine the expression levels of
the SCCA in these transfected cells and the parent cell line, semi-
quantitative RT-PCR of SCCA mRNA was performed. The cells
transfected with SCCA cDNA expressed remarkably higher levels
of SCCA mRNA, while the control and the parent cells did not
express SCCA mRNA (Figure 1). 
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Figure 1 Expression of SCCA1 and SCCA2 in 293T cells transfected with
SCCA1, SCCA2 cDNA or vector alone. Expression levels of SCCA1 and
SCCA2 mRNAs were determined by semi-quantitative RT-PCR. The upper
arrowhead indicates SCCA1 and SCCA2. The lower arrowhead indicates
L19 as an internal control. Lane 1 = 293T; Lane 2 = 293T-pCEP4; 
Lane 3 = 293T-SCCA1-1; Lane 4 = 293T-SCCA1-2; Lane 5 = 293T-SCCA2-1;
Lane 6 = 293T-SCCA2-2 Effect of SCCA1 and SCCA2 on the viability after
irradiation 
The growth rates of these transfected cells were evaluated with
MTT assay. However, there were no differences in the rate of cell
growth by the transfection of SCCA (Figure 2). We then investig-
ated the role of SCCA in the apoptosis induced by radiation. The
viable cells were measured by MTT assay until 36 h after exposure
to different doses of radiation. There were significant differences
in the viability between SCCA cDNA transfected clones and the
control cells irradiated with 5 Gy (Figure 3A) and 20 Gy (Figure
3B and Figure 4). 
Detection of caspase 2, 8 and 9 expression and
caspase 3 activity 
We evaluated the expression levels of bcl-2 and bax mRNAs in the
SCCA cDNA-transfected cells, the control cells, and the parent
cells. Each cell expressed bcl-2 and bax mRNAs and there were no
significant differences in the basal expression levels among these
cells. Furthermore, these expression levels were not altered by the
expression of SCCA1 and SCCA2 even after irradiation with 5 Gy
or 20 Gy, as measured by semi-quantitative RT-PCR (data not
shown). 
We then examined the expression levels of caspase 2, 8, and 9
with Western blotting and caspase 3 activity before and after
radiation treatment. As shown in Figure 5A, there were no signific-
ant differences in the expression level of caspase 8 and caspase 2
between the control cells and the cells transfected with SCCA
cDNAs. On the other hand, increase of the activated form of
caspase 9 after radiation treatment was suppressed in the SCCA-
transfected cells when compared to the control cells. Caspase 3
activity was also suppressed in the cells transfected with SCCA1
or SCCA2 cDNA (293T-SCCA1-1 or 293T-SCCA2-1) than that
of the control cells (293T-pCEP4) (Figure 5B). There were no
significant differences in the expression levels of caspase 2, 8, 
9 and caspase 3 activity between the control cells and SCCA
transfectants 12 and 24 h after irradiation treatment (data not 
shown). 
Expression levels of p38 MAPK and SAPK/JNK 
The apoptosis induced by stress like UV or irradiation has been
reported to induce phosphorylation of MAPK. We examined the
expression levels of p38 MAPK and SAPK/JNK by Western blot-
ting. As shown in Figure 6, there were no significant differences 
in the expression levels of total p38 MAPK among these cells.
However, expression level of phosphorylated p38 MAPK of
SCCA cDNA-transfected cells (293T-SCCA1-1 and 293T-
SCCA2-1) were significantly less than that of the control cells
before radiation treatment. When these cells were treated with
radiation 36 h after treatment, SCCA1 cDNA-transfected cells
(293T-SCCA1-1) showed a slight increase of phosphorylated p38
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Figure 2 Cell growth rate in 293T cells transfected with SCCA1, SCCA2
cDNA or vector alone. There were no significant differences in the cell growth
rate among every clone. These data were obtained in six independent
experiments and indicated as mean ± SEM  0
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Figure 3 Cell viability of SCCA cDNA transfectants after radiation. Cells
were cultured after radiation treatment with 5 Gy (A) or 20 Gy (B) for
indicated periods of time as described in ‘Materials and methods’, and the
viable cells were determined by MTT assay. These data were obtained in six
independent experiments and indicates as means ± SEM (*P < 0.05 for
293T-pCEP4 vs other clones; **P < 0.05 for 293T-pCEP4 vs SCCA2 cDNA
transfectants; ***P < 0.05 for 293T-pCEP4 vs SCCA1 cDNA transfectants;
****P < 0.01 for 293T-pCEP4 vs SCCA2 cDNA transfectants) MAPK, although it was still less than that of the control cells
(293T-pCEP4). In the case of SCCA2 cDNA-transfected cells
(293T-SCCA2-1), the cells were resistant to the increase of phos-
phorylated p38 MAPK. The activator of p38 MAPK (phosphoryl-
ated MKK3/MKK6) was present before the radiation treatment in
each cell. However, the expression level was decreased 36 h after
radiation treatment in SCCA-transfected cells, although it was
increased in the control cells. We could not find the differences of
the expression levels of phosphorylated p38 MAPK and
MKK3/MKK6 between the control cells and the SCCA transfec-
tants at 12 and 24 h (data not shown). On the other hand, there
were no significant differences in the expression levels of
SAPK/JNK and phosphorylated SAPK/JNK among the control
cells and SCCA transfectants with radiation treatment (data not
shown). 
DISCUSSION 
SCCA (SCCA1 and SCCA2) belongs to the ov-serpin family.
Some of the ov-serpin family has been reported as inhibiting apop-
tosis. For example, PAI-2 can inhibit the apoptosis induced by
TNF-a or Fas (Enari et al, 1995; Tewari and Dixit, 1995) and
PI-9 can inhibit granzyme B-induced apoptosis (Bird et al, 1998).
Furthermore, CrmA is able to inhibit apoptosis by suppressing
caspase 3 (Wagenknecht et al, 1998). Recently we reported that
SCCA1 significantly suppressed the apoptosis induced by anti-
cancer agent, TNF-a, (or activated natural killer (NK) cells
(Suminami et al, 2000). 
It has not been known how SCCA2 acts inside and/or outside of
the cell, although it has high homology with SCCA1. In a previous
report, it was suggested that SCCA2 may regulate inflammation
and tissue degradation by cathepsin G and mast cell chymase
within the epithelia of the skin because of the inhibition of these
proteinases in vitro (Schick et al, 1997). We demonstrated that
when SCCA was genetically engineered to express in 293T cells,
which did not express SCCA in the cell, apoptosis induced by
radiation treatment was significantly suppressed. This data
demonstrated that expression of SCCA2 in tumour cells, as well
as SCCA1, might contribute to the defence system of tumour 
cells, protecting them from apoptotic cell death induced by 
radiation. 
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Figure 4 The viable cells with radiation treatment after 36 h in the control
cells and the SCCA cDNA transfectants. The cells were treated with 20 Gy of
radiation and observed using phase contrast microscopy. (A) 293T-pCEP4,
(B) 293T-SCCA1-1, (C) 293T-SCCA2-1. Scale bar = 100 mm 
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Figure 5 Expression of caspases in the irradiated cells after 36 h. (A) Expression of caspase 2, 8 and 9 in the control cells and SCCA cDNA transfectants with
or without radiation treatment. In the middle panel, arrowhead indicates activated caspase 8. Upper and lower arrowheads indicate procaspase 9 and activated
caspase 9, respectively. Activation of caspase 9 was evaluated as a ratio of activated form and procaspase which was obtained by densitometric analysis and
indicated below each lane. (B) Caspase 3 activity in the control cells and SCCA cDNA transfectants with or without radiation treatment. Lane 1 = 293T-pCEP4;
Lane 2 = 293T-SCCA1-1; Lane 3 = 293T-SCCA2-1. These results are representative of three independent experiments Recently, a number of physiologic inhibitors of apoptosis have
been identified, including the Bcl-2 family members, inhibitor of
apoptosis protein family and the serpin family. Bcl-2 is one of the
most familiar inhibitors of apoptosis that is induced by various
stimuli. It prevents apoptosis; on the other hand Bax opposes the
function of Bcl-2 and hence promotes apoptosis. Bcl-2 binds with
Bax, prevent its homodimerzation and thus whether or not apop-
tosis occurs. It was reported that radiation treatment has been
shown to induce increases in bax mRNA in several cells (Zhan 
et al, 1994). Miyashita et al (1994) demonstrated that the expres-
sion level of Bcl-2 was down-regulated by p53. To know the
mechanism of inhibition of radiation-induced apoptosis by SCCA,
we first analysed the expression levels of bax and bcl-2 mRNAs
and p53 protein in SCCA1 or  SCCA2 cDNA-transfected cells.
However, they were not affected by the expression of SCCA.
Furthermore, there were no significant differences in the expres-
sion levels of bax and  bcl-2 mRNAs after radiation treatment
between the SCCA1 or SCCA2 cDNA-transfected cells and the
control cells. Therefore, in this study Bcl-2 and Bax did not affect
the regulation of cell death by SCCA. 
As some caspases sequentially process and activate others, a
model has been proposed in which some caspases (such as caspase
2, 8 or 9) act as initiator or signalling proteinases, while caspase 3
acts as an effector of apoptosis (Cohen, 1997). Previous studies
have suggested that caspase 9 is the most upstream member of the
apoptotic proteinases (Li et al, 1997). Caspase 3 is the most essen-
tial proteinase for the nuclear changes associated with apoptosis,
including chromatin condensation, and caspase 9 was the most
important participant for caspase 3 activation (Li et al, 1997).
These findings point to the existence of an apoptotic pathway
dependent on both caspase 9 and caspase 3. However, recent
studies suggested that comparison of the requirement for caspase 9
and caspase 3 in different apoptotic settings indicates the existence
of at least four different apoptotic pathways in mammalian cells
(Hakem et al, 1998). Our study suggested that, in 293T cells, radi-
ation preferentially triggers the activation of an apoptotic pathway
involving caspase 9 and caspase 3 activity and both SCCAs act in
this apoptotic cascade. 
The MAPK family plays an important role in cell growth,
differentiation, transformation and apoptosis (Cobb and
Goldsmith, 1995; Karin, 1995; Xia et al, 1995; Dickens et al, 1997;
Hunter, 1997). Recently several studies revealed that SAPK/JNK
activation and/or p38 MAPK activation were involved in apop-
tosis induced by different stimuli, such as radiation, UV and
osmotic shock-induced apoptosis (Sluss et al, 1994; Xia et al,
1995; Chen et al, 1996a, 1996b, 1999; Brenner et al, 1997).
Consistently, blockade of JNK activation promotes cell survival
(Park et al, 1996; Dickens et al, 1997). Although some reports
suggest that SAPK/JNK and/or the p38 MAPK pathways func-
tion primarily to promote apoptotic cell death, different reports
showing controversial results are observed in some systems
(Natoli et al, 1995; Lenczowski et al, 1997; Nishina et al, 1997;
Yang et al, 1997). 
Some reports propose that the duration and magnitude of p38
MAPK activation are major determinants of the cells fate (Guo et
al, 1998; Takekawa and Sato, 1998). Thus, the biochemical regula-
tion and cellular role of MAPK family in apoptosis cascades are
still to be clarified. In the present study, we examined whether
radiation stress induced phosphorylated SAPK/JNK and phospho-
rylated p38 MAPK, which were activated forms. In this study, p38
MAPK was less phosphorylated in the SCCA cDNA-transfected
cells, not only after radiation treatment but also before treatment.
Furthermore, phosphorylated MKK3/MKK6, which is the active
form of MAPK kinase and works just upstream of p38 MAPK,
was suppressed after radiation in the SCCA cDNA-transfected
cells, while that in the control cells was increased after radiation.
Therefore, in this system, p38 MAPK is proapoptotic, and SCCA1
and SCCA2 attenuate apoptosis by suppressing p38 MAPK
signalling at the step of phosphorylation of p38 MAPK and/or
MKK3/MKK6, although it is still unclear whether it affects the
phosphorylation directly or indirectly. 
In this study, radiation-mediated apoptosis induces activation 
of caspase 9, caspase 3 activity, and phosphorylation of MKK3/
MKK6 and p38 MAPK. The relationship between the signal
stream of caspases and the pathway of p38 MAPK has been
controversial. Now, there are three evidences in this relationship:
1. the activation of caspases was required for the activation of p38
MAPK (Natoli et al, 1997); 2. p38 MAPK stimulated the activity
of caspases (Nemoto et al, 1998; Zhang et al, 2000); 3. the 
early stage of JNK and p38 MAPK activation was a caspase-
independent pathway, but the late phase activation of them was a
caspase-independent pathway (Roulston et al, 1998). As we have
not analysed the effects of the inhibitors of p38 MAPK or
caspases, we can’t decide which one locates upstream in our
system. However, we speculate that p38 MAPK pathway locates
upstream of caspases, and SCCA affects the p38 MAPK pathway
first, inhibiting caspase 9 as a secondary effect, because phospho-
rylated p38 MAPK was suppressed in both SCCA transfectants
without radiation treatment. 
Recently it has been reported that serine proteinase inhibitor, 
N-tosyl-phenylalanine chloromethyl ketone (TPCK), inhibits apop-
tosis induced by Taxol, through the inhibition of the phosphoryla-
tion of c-Raf-1 and Bcl-2 (Huang et al, 1999). However, to our best
knowledge, this is the first report that serpin inhibits the phospho-
rylation of MAPK signalling pathway. We speculate that SCCA1
and SCCA2 indirectly regulate the phosphorylation by inhibiting
different factors which are involved in the p38 MAPK pathway
because SCCA1 and SCCA2 have different P1-P1¢ amino acids
which decide the target proteinases of serpin. The genes of SCCA1
and SCCA2 are tandemly located on chromosome 18q21.3 and they
are thought to be made as a result of gene duplication. Therefore,
although their target molecules may be different, it is reasonable
that they have similar functions. 
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Figure 6 Expression of p38 MAPK and MKK3/MKK6 in the control cells and
the SCCA cDNA transfectants with or without radiation treatment after 36 h.
Expression levels of kinases of p38 MAPK signals were determined by
Western blot analyses. Activation of p38 MAPK is indicated as a ratio of
densitometric intensity of phosphorylated form and total p38 MAPK. The ratio
of phosphorylated MKK3/MKK6 and total p38MAPK is also indicated. These
results are representative of three independent experiments We previously reported that the expression level of SCCA2
mRNA in cancer tissues was higher than that of normal tissues
(Murakami et al, 2000). However, it has been unclear why and
for what role SCCA2 increases in the SCC tissues. Although we
have already analysed the promoter region of the SCCA2 gene
(Sakaguchi et al, 1999), more detailed analysis would explain what
molecule stimulates the expression of SCCA2 in the case of malig-
nancy. Recently it has been reported that cathepsin G released
from neutrophil stimulates granzyme B of NK cells (Yamazaki 
and Aoki, 1998; Bird, 1999). Our preliminary data indicate that
secreted SCCA1 inhibits chemoinvasion of NK cells. As SCCA2
inhibits the cathepsin G in vitro, not only intracellular SCCA2 but
also secreted SCCA2 may augment the inhibitory function of
SCCA1 to apoptosis and be necessary for malignant tumours. 
In conclusion, our results suggested that both SCCAs inhibited
the apoptotic pathways induced by radiation. Overexpression of
SCCA in tumour cells appears to be in part responsible for the
protection of the cells from apoptosis in vitro and may be pro-
fitable for the cancer cells to protect them from the therapeutic
modalities. 
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